Press Releases News Year None202020192018201720162015201420132012 Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases Sep 19, 2017 | Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration Aug 14, 2017 | Ophthotech Reports Second Quarter 2017 Financial and Operating Results Jul 26, 2017 | Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases Jul 26, 2017 | Ophthotech Corporation to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, July 26, 2017 Jul 21, 2017 | Ophthotech Reports First Quarter 2017 Financial and Operating Results May 03, 2017 | Ophthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017 Apr 26, 2017 | Ophthotech Announces Leadership Transition Effective July 1, 2017 Apr 24, 2017 | Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results Feb 28, 2017 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on Tuesday, February 28, 2017 Feb 22, 2017 | Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last »
Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases Sep 19, 2017 |
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration Aug 14, 2017 |
Ophthotech Corporation to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, July 26, 2017 Jul 21, 2017 |
Ophthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017 Apr 26, 2017 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on Tuesday, February 28, 2017 Feb 22, 2017 |
Press Releases News Year None202020192018201720162015201420132012 Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases Sep 19, 2017 | Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration Aug 14, 2017 | Ophthotech Reports Second Quarter 2017 Financial and Operating Results Jul 26, 2017 | Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases Jul 26, 2017 | Ophthotech Corporation to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, July 26, 2017 Jul 21, 2017 | Ophthotech Reports First Quarter 2017 Financial and Operating Results May 03, 2017 | Ophthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017 Apr 26, 2017 | Ophthotech Announces Leadership Transition Effective July 1, 2017 Apr 24, 2017 | Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results Feb 28, 2017 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on Tuesday, February 28, 2017 Feb 22, 2017 | Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last »
Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases Sep 19, 2017 |
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration Aug 14, 2017 |
Ophthotech Corporation to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, July 26, 2017 Jul 21, 2017 |
Ophthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017 Apr 26, 2017 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on Tuesday, February 28, 2017 Feb 22, 2017 |
